Modera Wealth Management LLC Has $10.18 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Modera Wealth Management LLC cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 7.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 112,023 shares of the company’s stock after selling 8,538 shares during the quarter. Modera Wealth Management LLC’s holdings in Colgate-Palmolive were worth $10,184,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CL. Swedbank AB boosted its holdings in shares of Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after purchasing an additional 40,324 shares during the period. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $42,000. Stephens Inc. AR lifted its position in Colgate-Palmolive by 2.1% in the 3rd quarter. Stephens Inc. AR now owns 11,951 shares of the company’s stock worth $1,241,000 after buying an additional 251 shares in the last quarter. Creative Financial Designs Inc. ADV boosted its stake in shares of Colgate-Palmolive by 142.1% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 869 shares of the company’s stock valued at $90,000 after buying an additional 510 shares during the period. Finally, Gladstone Institutional Advisory LLC grew its holdings in shares of Colgate-Palmolive by 10.3% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 6,758 shares of the company’s stock valued at $702,000 after acquiring an additional 631 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.2 %

Shares of NYSE:CL opened at $91.27 on Friday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock’s 50-day moving average is $88.74 and its 200-day moving average is $95.48. The company has a market cap of $74.07 billion, a P/E ratio of 25.93, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.19%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.

Analysts Set New Price Targets

Several brokerages recently issued reports on CL. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Finally, Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $101.61.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.